By activating these incretin pathways, tirzepatide enhances insulin secretion in a glucose-dependent manner, suppresses inappropriate glucagon release, and slows gastric emptying
According to the American Journal of Clinical Nutrition, patients using GLP-1 medications can lose up to 25% of their weight as lean muscle rather than fat when protein intake drops below optimal levels
Patients should also consider cost, as compounded versions might initially seem more affordable, but their lack of proven safety could lead to additional medical issues or the need for further treatment
Always discuss your full medication list with your PlexusDx provider before starting oral tirzepatide
Newer approaches, such as activation of the Takeda G protein-coupled receptor 5 (TGR5
Triple Agonist Mechanism: GIP, GLP-1, and Glucagon Phase 2 Clinical Trial Data Phase 3 TRIUMPH Program Status Dosing Research Parameters Reconstitution: 5 mg and 30 mg Vials Storage and Stability Protocols Retatrutide vs